Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder defined by persistent patterns of inattention, hyperactivity, impulsivity, and emotional dysregulation. These symptoms are characterized as excessive, pervasive, and developmentally inappropriate, often leading to significant impairment across multiple life contexts. While it was formerly known as Attention Deficit Disorder (ADD), modern diagnostic standards categorize it under the broader ADHD umbrella.
The Three Presentations of ADHD
According to the sources, the condition is no longer viewed through rigid subtypes but rather through three primary presentations that can evolve over an individual’s lifetime.
- Predominantly Inattentive (ADHD-I): Symptoms include being easily distracted, forgetful, and having difficulty organizing tasks or following instructions.
- Predominantly Hyperactive-Impulsive (ADHD-HI): This presentation involves excessive motor activity, such as fidgeting, inability to remain seated, and a lack of forethought in decision-making.
- Combined Presentation (ADHD-C): Individuals in this category meet the criteria for both inattention and hyperactivity-impulsivity.
While overt hyperactivity often decreases with age, it frequently transforms into inner restlessness or constant mental activity in adults.
Biological and Genetic Underpinnings
The sources emphasize that ADHD is primarily a genetic disorder, with a heritability rate estimated between 70% and 80%. It is considered polygenic, meaning it arises from the accumulation of many genetic risks. Beyond genetics, certain environmental factors—typically biological rather than social—can contribute to the disorder, including prenatal exposure to lead, tobacco smoke, or alcohol, as well as extreme premature birth or traumatic brain injury.
Physiologically, ADHD is linked to functional impairments in dopamine and norepinephrine pathways that govern executive function, motivation, and reward perception. Structural imaging reveals that certain brain areas, particularly the left prefrontal cortex and various subcortical structures like the amygdala and hippocampus, often appear smaller in individuals with ADHD.
The Diagnostic Process
Diagnosis is a subjective clinical process rather than one based on a single biological test. Under the DSM-5 criteria, symptoms must be present for at least six months, have appeared before the age of 12, and occur in at least two settings, such as home and school. Clinicians utilize standardized rating scales, such as the Vanderbilt or Achenbach systems, and rely on feedback from multiple informants (parents, teachers, and patients) to ensure accuracy.
Management and Modern Treatments
A multifaceted approach is typically recommended for managing ADHD, often combining medication with behavioral therapy.
- Medication: Stimulants like methylphenidate and amphetamines are considered first-line treatments because they increase neurotransmitter activity in the prefrontal cortex. Non-stimulants such as atomoxetine (Strattera) and viloxazine are also used, particularly for those at risk of substance misuse.
- Behavioral Interventions: These are the recommended first-line treatment for preschool-aged children and include parent management training and cognitive-behavioral therapy.
- Digital Therapeutics: Recent innovations include FDA-authorized video game-based treatments, such as EndeavourRx, which have shown significant efficacy in improving objective measures of attention in both children and adults.
Long-Term Prognosis and Risks
The sources indicate that approximately 30–50% of children with ADHD continue to meet the criteria in adulthood. Untreated ADHD is associated with a range of negative outcomes, including poor academic achievement, higher rates of substance use disorders, and increased accident-proneness. Perhaps most critically, recent data suggest that ADHD is associated with a significant reduction in average life expectancy and an increased risk of suicide. Early and consistent management is therefore vital for improving the overall quality of life for those affected.